Kaitlyn D’Onofrio

DocwireNews

Although cognitive impairment is a common feature of multiple sclerosis (MS), there is not a lot of research available on specific cognitive phenotypes. A study categorized MS cognitive phenotypes and found that doing so may help guide treatment decisions and cognitive rehabilitation techniques.The study population consisted of patients with MS from eight MS centers in Italy and healthy controls. Eligibility criteria for all participants included not using psychoactive drugs as well as no history of other neurological or medical disorders, learning disability, severe head trauma, and alcohol or drug abuse.There were 1,212 patients with MS (mean age, 41.1 years [standard deviation (SD), 11.1 years]; 784 were female) and 196 healthy controls (mean age, 40.4 years [SD, 8.6 years]; 130 were female).The researchers established five cognitive phenotypes: preserved cognition (n=235 patients [19.4%]), mild&ndash;verbal memory/semantic fluency (n=362 patients [29.9%]), mild&ndash;multidomain (n=236 patients [19.5%]), severe&ndash;executive/attention (n=167 patients [13.8%]), and severe&ndash;multidomain (n=212 patients [17.5%]) involvement. Patients with preserved cognition and mild&ndash;verbal memory/semantic fluency were younger (mean age, 36.5 years [SD, 9.8 years] and 38.2 years [SD, 11.1 years], respectively) and had shorter disease duration (mean, 8 years [SD, 7.3 years] and 8.3 years [7.6 years], respectively) than patients with mild&ndash;multidomain (mean age, 42.6 years [SD, 11.2 years]; mean disease duration, 12.8 years [SD, 9.6 years];&nbsp;P&lt;0.001), severe&ndash;executive/attention (mean age, 42.9 years [SD, 11.7 years]; mean disease duration, 12.2 years [SD, 9.5 years];&nbsp;P&lt;0.001), and severe&ndash;multidomain (mean age, 44 years [SD, 11.0 years]; mean disease duration, 13.3 years [SD, 10.2 years];&nbsp;P&lt;0.001) phenotypes. Patients with progressive MS were more likely to have severe cognitive phenotypes.MRI evaluation found that, when compared with patients with preserved cognition, patients with mild&ndash;verbal memory/semantic fluency had lower mean hippocampal volume (5.42 mL vs. 5.13 mL; P=0.04), patients with the mild&ndash;multidomain phenotype had decreased mean cortical gray matter volume (687.69 mL vs. 662.59 mL; P=0.02), those with severe&ndash;executive/attention had higher mean T2-hyperintense lesion volume (51.33 mL vs. 99.69 mL; P=0.04), and patients with the severe&ndash;multidomain phenotype had decreased volume in all brain structures explored (except for nucleus pallidus, amygdala and caudate nucleus).&ldquo;These phenotypes can represent a more meaningful measure of the cognitive status of patients with MS and can help define clinical disability, support clinicians in treatment choices, and tailor cognitive rehabilitation strategies,&rdquo; the study authors concluded.

Bradley Marder, MD

Joel M. Topf, MD, FACP

Gout Studies: Transplant Waitlisting and Bone Erosion

NKF Spring Clinical Meetings 2025

Jayme Locke, MD, MPH

The Promise of Xenotransplantation

Leah Lawrence

Real-World Data Backs Invasive DFS as Surrogate Endpoint for OS in EBC

HR Breast Cancer

Latest News

Using MRI to Identify Distinct MS Phenotypes

Multiple Sclerosis

Although cognitive impairment is a common feature of multiple sclerosis (MS), there is not a lot of research available on specific cognitive phenotypes. A study categorized MS ...

About Us

Editorial Policy

Advertising

Contact Us

eNewsletters

Contribute

Career Center

MashupMD

Blood Cancers Today

Cancer Nursing Today

GU Oncology Now

Urban Health Today

Bile Duct Cancer

Colorectal Cancer

Gastroesophageal Cancer

Gastric Cancer

GEP-NETs

GIST

Liver Cancer

Pancreatic Cancer

GI Oncology Now

Anemia

Deep Vein Thrombosis

Essential Thrombocythemia

Hemophilia

Immune Thrombocytopenic Purpura

Myelodysplastic Syndromes

Myelofibrosis

Myeloproliferative Neoplasms

Polycythemia Vera

Pulmonary Embolism

Sickle Cell Disease

Thrombocytopenia

Thrombophilia

Thrombosis

Thrombotic Thrombocytopenic Purpura

Venous Thromboembolism

von Willebrand Disease

Heme Today

Acute Kidney Injury

ADPKD

Anemia and Kidney Disease

Chronic Kidney Disease

COVID-19 and Kidney Disease

Diabetes and Hypertension

End-Stage Renal Disease

Gout

Hyperkalemia

IgAN

Kidney Transplantation

Metabolic Acidosis

Nephrology Times

HER2 Breast Cancer

Triple-Negative Breast Cancer

Genetics & Breast Cancer

Breast Cancers Today

Atherosclerotic Disease

Atrial Fibrillation

Heart Failure

Hypertension

Interventional Cardiology

Lipid Management

Practice Tips With Dr. Lichaa

Preventive Cardiology

Stroke

Cardiology

Breast Cancer

Gynecologic Cancer

Head and Neck Cancer

Skin Cancer

Oncology

Sleep

Urology

Diabetes

Ophthalmology

— Demodex Blepharitis

Neurology

Rheumatology

Gastroenterology

Pulmonology

Infectious Diseases

— HIV

Health and Wellness

Lupus

Future of Medicine

Orthopedics

Pharmacology

Career News

More

Conferences

CardioNerds

The Sleep Source With Dr. Morse

Rheumatology Rounds With Dr. Maheswaranathan

Partners

Expert Interviews

Subscribe